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The cDNA for a 14 kDa human fl-galactoside-binding lectin was inserted into a plasmid carrying a taq promoter, and 
the lectin protein was expressed in E. coli cells. The recombinant leetin was extracted from the cells and purified to appar- 
ent homogeneity b  a single-step chromatography on an asialofetuin-agarose c lumn. Subunit molecular mass (14 kDa), 
hemagglutinating activity and antigenicity were indistinguishable from those ofthe human placental lectin. Though the 
N-terminal of the placental lectin is blocked with an acetyl group, the recombinant lec in was found to have a free amino 
group. However, the N-terminal mino acid sequences were identical. The recombinant lectin was considered tohave 
the same three-dimensional structure as the placental lectin. 
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1. INTRODUCTION 
Endogenous fl-galactoside-binding proteins (lec- 
tins) have been found in various vertebrate tissues 
and cells [1]. They are extractable with lactose and 
are specifically inhibited by ~'-galactoside- 
containing saccharides. Since they are often found 
in embryonic tissues and also in tumorigenic ells 
[2], they are supposed to have important func- 
tion(s) in some onco-developmental events. 
However, their physiological functions are not well 
understood. 
Complete primary sequences have been reported 
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for 14K-type lectins of chick skin [3,4], rat lung [5] 
and human placenta [6], and a nearly complete se- 
quence has also been determined for that of elec- 
tric eel [7]. The molecules all consist of 134 amino 
acids and show 50-90°7o sequence homology. They 
have free thiol groups instead of disulfide bridges, 
and as far as examined, their N-terminal amino 
groups are blocked. We recently isolated a full- 
length cDNA clone for a human 14K-type lectin 
from a lung cDNA library [8], and determined its 
nucleotide sequence; the deduced amino acid se- 
quence was identical with that of the human 
placental 14K-type lectin [6,9,10]. The result sug- 
gested the absence of a signal sequence required 
for secretion as in the cases of chick [3] and rat [5] 
lectin cDNAs. Recently, a cDNA for mouse 35K- 
type lectin was cloned and the deduced amino acid 
sequence was reported. Its C-terminal half showed 
a significant homology to the 14K-type lectins, 
while its N-terminal half has some homology with 
proteins of the heterogeneous ribonucleoprotein 
complex [11], We pointed out that 14K-type lectins 
have approximately 30070 sequence homology to 
the C-terminal half of one of the IgE-binding pro- 
teins isolated from rat basophilic leukemia cells 
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(designated eBP in [12]), and also that the mouse 
35K-type lectin is a possible counterpart of rat eBP 
in mouse [8]. These results suggest that some ,& 
galactoside-binding lectins are involved in the 
metabolism of nucleic acids and in the regulation 
of the immune system. In this context, Levi et al. 
demonstrated prophylactic and therapeutic effects 
of an electric eel lectin on experimental autoim- 
mune disease [ 131. We also found that human 
placental lectin could trigger the production by 
primed macrophages of a cytotoxin capable of 
destroying malignant cells [ 141. 
These findings emphasize the importance of an 
extensive study of p-galactoside-binding lectins. 
Here, we report the expression of the human 14K- 
type P-galactoside-binding lectin in E. coli. We in- 
serted the cDNA cloned from a human lung library 
into a plasmid carrying a taq promoter, and suc- 
ceeded in producing up to 2 mg of the recombinant 
protein from l-l culture by a simple procedure. 
The recombinant lectin was indistinguishable from 
the placental lectin except that the N-terminal 
amino acid is not blocked. The expression system 
thus established should provide a basis for extend- 
ed studies on /3-galactoside-binding lectins from 
vertebrates. 
2. EXPERIMENTAL 
2.1. The construction of the expression plasmid pHI4GAL 
A 0.39-kb DNA fragment encoding most of the amino acid 
sequence of the human 14K-type lectin was prepared from the 
HinfI and NcoI digest of a full-length cDNA clone LD9-3 
(0.9 kb) [8], which contains a unique Hinff site 27 nucleotides 
downstream of the initiation codon and a unique NcoI site 12 
nucleotides downstream of the termination codon. Two single- 
stranded DNA fragments were synthesized with an Applied 
Biosystems 381A synthesizer; one is a 35-mer of sequence 
5 ’ -GATCC ATG GCT TGT GGT CTG GTC GCC AGC AAC 
CTG-3 ’ containing the initiation codon ATG at positions 6-8, 
and the other is a complementary 34-mer, 5’-ATT CAG GTT 
GCT GGC GAC CAG ACC ACA AGC CAT G-3 ’ . These 
fragments were annealed and ligated with the 0.39-kb cDNA 
fragment. Downstream of the NcoI site, we inserted a 90-bp 
fragment obtained from another cDNA clone LAl-2 (0.4 kb) 
[8] by cutting at the same NcoI site as that in clone LD9-3 and 
at a PstI site that originated from pUCl8. This procedure pro- 
duced a fragment (0.51 kb) which has EamHI and PstI sites at 
both termini. The fragment was inserted immediately 
downstream of the taq promoter of a BamHI/PstI-cut expres- 
sion vector pUC540 (KanR), which is a derivative of pUC540 
with added kanamycin resistance 1151. The size and orientation 
of the insert were examined by comparing the restriction map 
produced by Hinfl, EcoRI and BamHI with that of pUC540 
162 
(KanR). Nucleotide sequences around the ligation sites were 
confirmed by the dideoxy chain termination method [16] using 
the synthetic 35-mer and a commercially available Ml3 primer. 
2.2. Western-blotting analysis 
E. coli strains of SCSl and YlO90 were transformed with 
pHl4GAL by the procedure of Hanahan [17]. Cells were grown 
in an appropriate medium containing ampicillin (50 @g/ml), 
kanamycin (30 pg/ml) and isopropyl-D-D-thiogalactopyrano- 
side (IPTG, 0.1 mM). To prepare either lactose extract or 
lactose-free xtract, cells were collected by centrifugation, and 
were suspended in the original volume of EDTA/PMSF/ 
MEPBS (2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 
4 mM 2-mercaptoethanol, 20 mM sodium phosphate, pH 7.2, 
0.15 M sodium chloride) or 0.1 M lactose in EDTA/PMSF/ 
MEPBS. Cells were disrupted by sonication with a Branson 
Sonifier. After removal of the cell debris, each extract was 
analyzed by polyacrylamide gel electrophoresis n the presence 
of SDS. For Western-blotting experiments, separated proteins 
were electrophoretically transferred to a polyvinylidenedi- 
fluoride (PVDF) membrane, Immobilon (Millipore). After ex- 
tensive blocking with 1% skim milk (Morinaga Co. Ltd, Tokyo, 
Japan), the membrane was sequentially treated with lOOO-fold- 
diluted anti-human placental lectin antiserum [lo] (16 h, at 
room temperature), and with lOOO-fold-diluted horseradish 
peroxidase-labeled (goat) anti-rabbit IgG (Miles) (2 h, at room 
temperature). After extensive washing, the membrane was 
stained with a Konica Immunostain Kit (Tokyo, Japan) as 
described previously [8]. 
2.3. Purification of the recombinant lectin from E. coli 
Transformed cells were grown in 4-20 1 of an appropriate 
medium containing antibiotics and IPTG (0.1 mM), collected 
by centrifugation, and suspended in approximately 10 ml/l 
culture of EDTA/PMSF/MEPBS. Cells were disrupted by 
sonication (3 min, at O”C, three times at 1 min intervals) and 
the resultant suspension was centrifuged to remove debris. 
Then, clear supernatant solution was applied to an asialofetuin- 
agarose column (1.8 x 15 cm, 9 mg fetuin/ml gel) prepared as 
described [18], and after extensive washing of the column with 
EDTA/MEPBS, an adsorbed material was eluted with 
EDTA/MEPBS containing 0.1 M lactose. 
Hemagglutinating activity was measured as described (191. 
Protein concentration was determined by the method of Brad- 
ford (201. Lipopolysaccharide (LPS) content of the purified 
sample was determined with a calorimetric endotoxin deter- 
mination reagent, Pyrodick (Seikagaku Kogyo Co. Ltd, Tokyo, 
Japan). The N-terminal amino acid sequence was determined 
with an Applied Biosystems 477A pulsed-liquid sequencer. 
3. RESULTS AND DISCUSSION 
We constructed an expression plasmid 
pH14GAL from the plasmid pUC540 (KanR) [ 151 
and a cDNA for a 14K-type lectin derived from a 
human lung cDNA library [8] as described in sec- 
tion 2. The initiation codon ATG was linked im- 
mediately downstream of the taq promoter via a 
synthetic BamHI linker (see fig.1). 
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35-met- 5’ GATCC ATG GCT TGT GGT CTG GTC GCC AGC AAC CTG 3' 
34-mer 3' G TAC CGA ACA CCA GAC CAG CGG TCG TTG GAC TTA 5' 
K MCS 
5.0 kbp I 
Fig.1. Construction of the expression plasmid pH14GAL. A 
segment map and the sequence in the ligated region of the 
synthetic 35/34-mer are shown. The lectin cDNA shown by a 
thick arrow was inserted immediately downstream of the taq 
promoter/operator region of pUC540 (KanR). The lectin- 
coding region is shaded. B, EarnHI; N, NcoI; H, HinfI; E, 
EcoRI sites. MCS is a multi-cloning site that originates from 
pUC8 and pUC18. 
Fig.2. The result of Western-blotting analysis. E. coli SCSl was 
transformed with pUC540 (KanR) (lane 1) and pH14GAL (lanes 
2-6). In every case, materials equivalent o lo/t1 culture were 
subjected to the analysis. Lanes: 1, 2, whole culture fractions; 
3, pellet (cell) fraction; 4, supernatant (medium) fraction; 5, 
lactose extract; 6, lactose-free xtract; 7, purified recombinant 
lectin (50 ng); 8, purified placental ectin (50 ng). Arrowheads 
indicate the eluting positions of bovine serum albumin 
(66 kDa), chicken ovalbumin (35 kDa), bovine carbonic 
anhydrase B (30 kDa), bovine ,&lactoglobulin (18.4 kDa) and 
Fig.3. The result of 15% polyacrylamide gel electrophoresis n 
the presence of SDS. Proteins were stained with Coomassie 
blue. Lanes: 1, molecular mass markers (1 /cg each); 2, purified 
placental lectin (1 fig); 3, lactose-free extract of SCSl cells 
transformed with pH14GAL (lOO+l culture equivalent); 4, 
purified recombinant lectin (0.5pg); 5 and 6, whole culture 
fractions of SCSl transformed with pH14GAL and pUC540 
(KanR), respectively (both lO-~1 culture equivalents). 
Arrowheads indicate the eluting positions of marker proteins of 
rabbit phosphorylase b (97 kDa), bovine serum albumin 
(66 kDa), chicken ovalbumin (45 kDa), bovine carbonic 
anhydrase B (30 kDa), soybean trypsin inhibitor (20 kDa) and 
chicken lysozyme (14.3 kDa). bovine cr-lactalbumin (14.2 kDa). 
Both transformed E. coli strains, SCSl and 
Y1090, produced the recombinant lectin in the 
presence of 0.1 mM IPTG. The result of Western- 
blotting analysis of proteins produced by the 
pH14GAL-transformed SCSl is presented in fig.2. 
Lane 2 shows that the whole culture of pH14GAL- 
transformed cells gave a specific 14 kDa band 
stained with anti-human placental lectin an- 
tiserum. However, no corresponding band was 
detected in lane 1 (transformed with the vector on- 
ly). Lanes 3 and 4 show the results of analysis of 
both cells and medium. Only the cell fraction gave 
the lectin band. This is consistent with the fact that 
163 
Volume 250, number 2 FEBS LETTERS July 1989 
the hemagglutinating activity was not detected in 
the culture medium. 
The effect of a hapten sugar on the efficiency of 
extraction of the recombinant lectin was also ex- 
amined. The lectin was extracted from the cells 
either in the presence or absence of lactose, which 
usually facilitates the extraction of the 14K-type 
lectins from vertebrate tissues [9]. However, the 
lactose-free extract showed a hemagglutinating ac- 
tivity as high as that of the lactose extract (the ac- 
tivity was measured after the removal of lactose by 
dialysis). In both fractions, hemagglutinating ac- 
tivity was inhibited almost completely (more than 
90%) by 7.5 mM lactose. Western-blotting pat- 
terns of both fractions were essentially identical 
(lanes 5 and 6 in fig.2). Moreover, almost equal 
amounts of the lectin were purified from both ex- 
tracts (data not shown). This suggests that the 
recombinant lectin did not bind to insoluble 
materials of E. coli via the sugar-binding site. E. 
coli does not seem to have an endogenous receptor 
for the lectin. No evidence has appeared of the ex- 
istence in E. coli of ,8-galactoside-binding lectins 
corresponding to those of vertebrates [21,22]. 
Purification of the recombinant lectin was great- 
ly facilitated, because lactose was unnecessary for 
extraction of the lectin, and so no step for the 
subsequent removal of lactose was required. The 
E. coli extract containing the lectin was directly ap- 
plied to an asialofetuin-agarose column, and the 
recombinant lectin was eluted with lactose after ex- 
tensive washing of the column. No hemag- 
glutinating activity was detected in a flow-through 
fraction. The eluted protein gave a single band in 
polyacrylamide gel electrophoresis, and had the 
same mobility as the placental lectin, corre- 
sponding to a monomeric molecular mass of 
14 kDa (lane 4 in fig.3). It was also reactive with 
antiserum raised against he placental ectin (lane 7 
in fig.2). Specific hemagglutinating activity of the 
recombinant lectin was almost the same as that of 
the placental lectin; the minimum concentration 
required for the hemagglutination was approx- 
imately 1 pg/ml. The yields were 0.9 and 2.0 mg/l 
culture for SCSl and Y1090, respectively. Thus, it 
might be possible to prepare more than 100 mg of 
the lectin in a week. Asialofetuin-agarose 
chromatography was also effective for the removal 
of endotoxin lipopolysaccharide (LPS) that 
originated from E. coli; the LPS content in the 
purified lectin was as low as 60 ng/mg protein. 
Although the N-terminus of the placental ectin is 
acetylated [6], N-terminal sequence analysis show- 
ed that the recombinant lectin was not blocked at 
its N-terminus. This result is consistent with the 
general observation that N-terminal acetylation is 
rare in bacteria and fungi [23]. However, the se- 
quence was identical with that of the placental ec- 
tin [6] up to 39 residues (fig.4). Since the 
hemagglutinating activity of the recombinant lec- 
tin was almost the same as that of the placental ec- 
tin, the acetyl group is not essential for the correct 
folding of the protein or the formation of the 
sugar-binding site. 
This system for production of the recombinant 
lectin should not only provide a basis for extended 
studies, e.g. site-directed mutagenesis, but also 
make available large quantities of the human lec- 
tin, which might be interesting from the medical 
viewpoint. 
Placenta 
lectin 
5 ___ 10 15 20 
Ac-Ala-Cys-Gly-Leu-Val-Ala-Ser-Asn-Leu-Asn-Leu-Lys-Pro-Gly-Glu-Cys-Leu-Arg-Val-Arg- 
Recombinant 
lectin H-Ala-( )-Gly-Leu-Val-Ala-Ser-Asn-Leu-Asn-Leu-Lys-Pro-Gly-Glu-( )-Leu-Arg-Val-Arg- 
Placenta 25 30 35 40 
lectin Gly-Glu-Val-Ala-Pro-Asp-Ala-Lys-Ser-Phe-Val-Leu-Asn-Leu-Gly-Lys-Asp-Ser-Asn-Asn- 
Recombinant 
lectin Gly-Glu-Val-Ala-Pro-Asp-Ala-Lys-Ser-Phe-Val-Leu-Asn-Leu-Gly-Lys-Asp-Ser-Asn-( )- 
Fig.4. The result of N-terminal sequence analysis of the recombinant lectin and comparison with the sequence of a human placental 
lectin. No cysteine residue was detected (ND), as the intact recombinant protein was directly applied to a sequencer. The sequence 
of the placental ectin was taken from [6]. 
164 
Volume 250, number 2 FEBS LETTERS July 1989 
During preparation of this manuscript, Couraud 
et al. presented results on the expression of a 
14 kDa fi-galactoside-binding lectin isolated from 
human promyelocytic leukemia cells HL60 [24]. 
Their results were essentially similar to those of 
ours. Since no 14 kDa lectin could be detected in 
macrophages, cells of a more advanced differential 
stage ([25] Oda and Kasai, unpublished observa- 
tion), the presence of the 14 kDa lectin in HL60 
cells may imply that the lectin plays a significant 
role in cell differentiation. 
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